Unknown

Dataset Information

0

Image-based 384-well high-throughput screening method for the discovery of skyllamycins A to C as biofilm inhibitors and inducers of biofilm detachment in Pseudomonas aeruginosa.


ABSTRACT: To date, most antibiotics have primarily been developed to target bacteria in the planktonic state. However, biofilm formation allows bacteria to develop tolerance to antibiotics and provides a mechanism to evade innate immune systems. Therefore, there is a significant need to identify small molecules to prevent biofilm formation and, more importantly, to disperse or eradicate preattached biofilms, which are a major source of bacterial persistence in nosocomial infections. We now present a modular high-throughput 384-well image-based screening platform to identify Pseudomonas aeruginosa biofilm inhibitors and dispersal agents. Biofilm coverage measurements were accomplished using non-z-stack epifluorescence microscopy to image a constitutively expressing green fluorescent protein (GFP)-tagged strain of P. aeruginosa and quantified using an automated image analysis script. Using the redox-sensitive dye XTT, bacterial cellular metabolic activity was measured in conjunction with biofilm coverage to differentiate between classical antibiotics and nonantibiotic biofilm inhibitors/dispersers. By measuring biofilm coverage and cellular activity, this screen identifies compounds that eradicate biofilms through mechanisms that are disparate from traditional antibiotic-mediated biofilm clearance. Screening of 312 natural-product prefractions identified the cyclic depsipeptide natural products skyllamycins B and C as nonantibiotic biofilm inhibitors with 50% effective concentrations (EC50s) of 30 and 60 ?M, respectively. Codosing experiments of skyllamycin B and azithromycin, an antibiotic unable to clear preattached biofilms, demonstrated that, in combination, these compounds were able to eliminate surface-associated biofilms and depress cellular metabolic activity. The skyllamycins represent the first known class of cyclic depsipeptide biofilm inhibitors/dispersers.

SUBMITTER: Navarro G 

PROVIDER: S-EPMC3910817 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Image-based 384-well high-throughput screening method for the discovery of skyllamycins A to C as biofilm inhibitors and inducers of biofilm detachment in Pseudomonas aeruginosa.

Navarro Gabriel G   Cheng Andrew T AT   Peach Kelly C KC   Bray Walter M WM   Bernan Valerie S VS   Yildiz Fitnat H FH   Linington Roger G RG  

Antimicrobial agents and chemotherapy 20131202 2


To date, most antibiotics have primarily been developed to target bacteria in the planktonic state. However, biofilm formation allows bacteria to develop tolerance to antibiotics and provides a mechanism to evade innate immune systems. Therefore, there is a significant need to identify small molecules to prevent biofilm formation and, more importantly, to disperse or eradicate preattached biofilms, which are a major source of bacterial persistence in nosocomial infections. We now present a modul  ...[more]

Similar Datasets

| S-EPMC8216101 | biostudies-literature
| S-EPMC7246797 | biostudies-literature
| S-EPMC8748891 | biostudies-literature
| S-EPMC2043262 | biostudies-literature
| S-EPMC3008242 | biostudies-literature
| S-EPMC3811817 | biostudies-literature
2021-06-14 | PXD023374 | Pride
2021-06-14 | PXD019733 | Pride
| S-EPMC1182440 | biostudies-literature
| S-EPMC5526060 | biostudies-other